Penumbra (PEN) Non Operating Income (2014 - 2023)
Penumbra's (PEN) quarterly Non Operating Income came in at $3.6 million in Q4 2023, up 276.68% year-on-year from $951214.0 in Q4 2022, and up 219.06% on a QoQ basis from $1.1 million in Q3 2023.
Penumbra (PEN) Non Operating Income (2014 - 2023) Analysis & Trends
Penumbra (PEN) has 10 years of Non Operating Income data on file, last reported at $3.6 million in Q4 2023.
- On a quarterly basis, Non Operating Income rose 276.68% year-over-year to $3.6 million in Q4 2023; TTM through Dec 2023 was $6.1 million, a 378.49% increase from a year earlier, with the FY2025 full-year figure at $15.9 million, up 36.98% from the prior year.
- Non Operating Income for Q4 2023 stood at $3.6 million, up from $1.1 million in the prior quarter.
- Over the last five years, Non Operating Income for PEN reached as high as $3.6 million in Q4 2023 and fell as low as -$3.9 million in Q4 2021.
- Historically, Non Operating Income has averaged $251450.0 across 5 years, with a median of $430000.0 in 2020.
- Across the five-year window, Non Operating Income plunged 976.51% in 2021 and jumped 2711.63% in 2023, its largest moves.
- Year by year, Non Operating Income stood at $578000.0 in 2019, then retreated by 22.66% to $447000.0 in 2020, then plunged by 976.51% to -$3.9 million in 2021, then jumped by 48.24% to -$2.0 million in 2022, then soared by 276.68% to $3.6 million in 2023.
- Per Business Quant data, the three most recent Non Operating Income figures were $3.6 million in Q4 2023, $1.1 million in Q3 2023, and $839000.0 in Q2 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 62.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -18.60 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Penumbra | 12.48 Bn | 11.87 Bn | 253.41 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 3.58 Mn |
| Sep 30, 2023 | 1.12 Mn |
| Jun 30, 2023 | 839,000.00 |
| Mar 31, 2023 | 554,000.00 |
| Dec 31, 2022 | -2.03 Mn |
| Sep 30, 2022 | -43,000.00 |
| Jun 30, 2022 | -72,000.00 |
| Mar 31, 2022 | -47,000.00 |
| Dec 31, 2021 | -3.92 Mn |
| Sep 30, 2021 | 138,000.00 |
| Jun 30, 2021 | 299,000.00 |
| Mar 31, 2021 | 480,000.00 |
| Dec 31, 2020 | 447,000.00 |
| Sep 30, 2020 | 413,000.00 |
| Jun 30, 2020 | 108,000.00 |
| Mar 31, 2020 | 299,000.00 |
| Dec 31, 2019 | 578,000.00 |
| Sep 30, 2019 | 759,000.00 |
| Jun 30, 2019 | 784,000.00 |
| Mar 31, 2019 | 733,000.00 |